![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/11\/4671-1604508642.jpg\")
<\/p>\n<\/p>\n
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed \/ shelved drug development programs<\/em><\/p>\n Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.<\/a>”<\/p>\n The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing \/ repositioning \/ reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:<\/p>\n Key companies covered in the report<\/a><\/p>\n For more information please click on the following link:<\/p>\n https:\/\/www.rootsanalysis.com\/reports\/drug-repurposing-service-provides.html<\/a><\/p>\n Other Recent Offerings<\/strong><\/p>\n About Roots Analysis<\/strong><\/p>\n Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n Contact Information<\/strong><\/p>\n Roots Analysis Private Limited Tags: drug reprofiling<\/a>, drug repositioning. drug discovery<\/a>, pharma<\/a>, biotech<\/a>, drug development<\/a>, Analysis<\/a>, Roots Analysis<\/a>, Drug Repurposing<\/a>, <\/a><\/p>\n Roots Analysis Tags:<\/b> Gaurav Chaudhary Roots Analysis\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\nGaurav Chaudhary
\n+1 (415) 800 3415
\ngaurav.chaudhary@rootsanalysis.com<\/p>\nSee Campaign: <\/strong>https:\/\/www.rootsanalysis.com\/<\/a>
Contact Information:<\/b>
Gaurav Chaudhary
\ngaurav.chaudhary@rootsanalysis.com<\/p>\n
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n
<\/a>, IPS<\/a>, Reportedtimes<\/a>, Wire<\/a>, iCN Internal Distribution<\/a>, Extended Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\ngaurav.chaudhary@rootsanalysis.com<\/p>\n
\nA430, 4th Floor,
\nBestech Business Towers, Sector 66, Mohali, India
\nsales@rootsanalysis.com
\n+1 (415) 800 3415
\n+44 (122) 391 1091
\nWeb: https:\/\/www.rootsanalysis.com\/
\nLinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis
\nTwitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed \/ shelved drug development programs Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.” The report features … Continue reading The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis<\/span><\/a> Continue Reading